TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cooperative behavior scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: heart rate measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propofol dose required for sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Satisfaction with operative result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reflux control effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: visceral fat area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median MSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in average number of medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in mean number of doses per day
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cost per case
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alcohol use among tenth-graders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach an Aldrete score of at least 9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inability to carry out normal work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: moderate or severe lethargy
Endpoint domain: Adverse events/effects
Primary endpoint: Uric Acid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endothelial Reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: GerdQ index reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom resolution or acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Excellent or good results after OAT and MF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failures in the MF group
Endpoint domain: Adverse events/effects
Primary endpoint: Magnetic resonance imaging evaluation results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lipoprotein(a) (Lp[a]) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative burst capacity of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of nights spent in hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Post-operative analgesia necessity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean menstrual blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total scar count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of subjects clear/almost clear (SGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in inflammatory acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Trough FEV1 improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TDI focal score improvements
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SGRQ score improvements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in circulating endothelial cells (∆aCECs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight gain after one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD loss at total hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Student learning in clinical urology
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Jugular venous distension (JVD) >12 cmH2O
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right atrial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anticancer efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: reduced Ki67+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: increased TUNEL+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain (VAS results)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 s-chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: gingival recession
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improved attitudes toward each other
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Less conflict reported by families
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lower likelihood of staff quitting
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incident opacities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: cumulative risk of lens opacity formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Satisfaction with hospital care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Laparoscopic skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FT(4) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: TSH plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative risk of vertebral and nonvertebral fractures
Endpoint domain: Mortality/survival
Primary endpoint: percentage of diarrhoeal stools per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: consumption of loperamide
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: serum vitamin B12 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Clinical Attachment Level (CBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of morphine required during the postoperative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of oxycodone required during the postoperative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients requiring additional morphine at 2 h postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute increase in femoral neck aBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: percentage increase in femoral neck aBMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: absolute increase in lumbar spine BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HER2 positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance rate for FISH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance rate for IHC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gains in accuracy of production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intelligibility across time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating Tumor Cells (CTCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proteinuria decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cure rates at day 28 of follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net fluid balance at the end of cardiopulmonary bypass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SF-36 MH scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of participants attaining 21 or more days of continuous abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported percent days of abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in spontaneous oscillatory MEG activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of additional vascular imaging procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SF-36 Mental Health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cholesterol goals achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hyperlipidemia knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: increased motivation to exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in daily routines
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: run times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obliteration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: permanent major ischemic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of episodes of postoperative emesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to goal feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: infarct segment length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean time to return to normal activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Median ALT after 20 h of acetylcysteine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Time of hospitalization
Endpoint domain: Resource use
Primary endpoint: Serum Sodium Concentration (SSC) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient postoperative hypocalcemia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean cumulated serum calcium values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean oral calcium supplementation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Interpretation of edema volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of death and ischemic events
Endpoint domain: Mortality/survival
Primary endpoint: lung function tests (FEV1 and FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ear symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intermetatarsal angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain, satisfaction, and function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduction in total and visceral fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: delay in menarche
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ratings of spirituality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ratings of gratitude
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self‐compassion ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrent instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of OS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical response rates (nPSA1 and nPSA05)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of frusemide required to achieve target diuresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean urine output per dose of frusemide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time to onset of motor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of motor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meconium aspiration syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Feed intolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Bone retention in Gruen zone 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Harris hip score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Oxford hip score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: successful pregnancy rate
Endpoint domain: Mortality/survival
Primary endpoint: body weight of infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of PMS/HPF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of apolipoproteins A-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of apolipoproteins A-II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LFO amplitudes after CPAP therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rhinorrhea resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sneezing resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete or partial tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sensitivity of assays for B19 DNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour urine calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: serum 25 (OH) D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total intensity of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Encouragement of genetic counseling before testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exploration of genetic counseling benefits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asking about family history of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve for tissue perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Framingham 10-year CHD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery to first analgesic time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing without further intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaustion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Disengagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone Mineral Density (BMD) T-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of block to touch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of diabetic patients inadequately controlled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in recommended glycohemoglobin (HbA1c) testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ambulatory visit rates
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: teacher ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary composite end-point
Endpoint domain: Mortality/survival
Primary endpoint: daily core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of adhesion molecules (P-selection, ICAM-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity for elevated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perspective taking scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prosocial behaviour
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Household direct costs of seeking care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time spent seeking care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of worsening in UPDRS score between weeks 12 and 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening in UPDRS score between baseline and week 72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in UPDRS score between weeks 48 and 72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with zero seizures during the monotherapy phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful monotherapy sustained for at least 7 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tolerability of lamotrigine compared to carbamazepine and valproate
Endpoint domain: Adverse events/effects
Primary endpoint: blood absorption measured as total iron content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: epithelialization of wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of prostate cancer
Endpoint domain: Mortality/survival
Primary endpoint: Cerebrospinal fluid leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Negative and depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment default rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: LFCN sensory nerve action potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Constant score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to normal shoulder ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Fitness for Work Certificates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Information regarding working capacity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attested work capacity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in IRLS at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on the CGI scale at week 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: risk of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: duration of hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAPE‐V ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: harmonic‐to‐noise ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Chemerin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentrations of proteins and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: One-year remission rate
Endpoint domain: Mortality/survival
Primary endpoint: Intraocular Pressure (IOP) levels at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes